BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peulen H, Mantel F, Guckenberger M, Belderbos J, Werner-wasik M, Hope A, Giuliani M, Grills I, Sonke J. Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 2016;96:134-41. [DOI: 10.1016/j.ijrobp.2016.04.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Pougnet I, Habert P, Delcourt S, Boucekine M, Wong S, Zacchariotto A, Muracciole X, Gaubert J, Padovani L. Local Recurrence Risk Score to Predict Relapse after Stereotactic Body Radiation Therapy for Lung Tumors. JCM 2022;11:6445. [DOI: 10.3390/jcm11216445] [Reference Citation Analysis]
2 Rodríguez De Dios N, Navarro-Martin A, Cigarral C, Chicas-Sett R, García R, Garcia V, Gonzalez JA, Gonzalo S, Murcia-Mejía M, Robaina R, Sotoca A, Vallejo C, Valtueña G, Couñago F. GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer. World J Clin Oncol 2022; 13(4): 237-266 [DOI: 10.5306/wjco.v13.i4.237] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Daly ME. Inoperable Early-Stage Non-Small-Cell Lung Cancer: Stereotactic Ablative Radiotherapy and Rationale for Systemic Therapy. J Clin Oncol 2022;40:539-45. [PMID: 34985921 DOI: 10.1200/JCO.21.01611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Tisi S, Lawrence D, Antoniou S. Management of Local Disease in NSCLC. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00166-9] [Reference Citation Analysis]
5 Lee K, Le T, Hau E, Hanna GG, Gee H, Vinod S, Dammak S, Palma D, Ong A, Yeghiaian-Alvandi R, Buck J, Lim R. A systematic review into the radiological features predicting local recurrence after stereotactic ablative body radiotherapy (SABR) in patients with non-small cell lung cancer (NSCLC): Local recurrence features of NSCLC post-SABR. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)03235-1. [PMID: 34879247 DOI: 10.1016/j.ijrobp.2021.11.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Vlaskou Badra E, Baumgartl M, Fabiano S, Jongen A, Guckenberger M. Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research. Transl Lung Cancer Res 2021;10:1930-49. [PMID: 34012804 DOI: 10.21037/tlcr-20-860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Christie JR, Lang P, Zelko LM, Palma DA, Abdelrazek M, Mattonen SA. Artificial Intelligence in Lung Cancer: Bridging the Gap Between Computational Power and Clinical Decision-Making. Can Assoc Radiol J. 2021;72:86-97. [PMID: 32735493 DOI: 10.1177/0846537120941434] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
8 Yang WC, Hsu FM, Yang PC. Precision radiotherapy for non-small cell lung cancer. J Biomed Sci 2020;27:82. [PMID: 32693792 DOI: 10.1186/s12929-020-00676-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
9 Chassagnon G, Martini K, Giraud P, Revel MP. Radiological assessment after stereotactic body radiation of lung tumours. Cancer Radiother 2020;24:379-87. [PMID: 32534799 DOI: 10.1016/j.canrad.2020.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Frerker B, Hildebrandt G. Distinguishing Radiation Pneumonitis from Local Tumour Recurrence Following SBRT for Lung Cancer

]]>. RMI 2020;Volume 13:1-23. [DOI: 10.2147/rmi.s176901] [Reference Citation Analysis]
11 Kim TH, Woo S, Halpenny DF, Kim YJ, Yoon SH, Suh CH. Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis. Eur J Radiol 2020;127:108978. [PMID: 32298960 DOI: 10.1016/j.ejrad.2020.108978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Yossi S, Nguyen D, Krhili S, Lizée T, Khodri M. [Prognosis factors after lung stereotactic body radiotherapy for non-small cell lung carcinoma]. Cancer Radiother 2020;24:267-74. [PMID: 32192839 DOI: 10.1016/j.canrad.2019.11.002] [Reference Citation Analysis]
13 Venturini M, Cariati M, Marra P, Masala S, Pereira PL, Carrafiello G. CIRSE Standards of Practice on Thermal Ablation of Primary and Secondary Lung Tumours. Cardiovasc Intervent Radiol 2020;43:667-83. [PMID: 32095842 DOI: 10.1007/s00270-020-02432-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
14 Larici AR, Farchione A, Cicchetti G, del Ciello A, Mantini G, Calapaquí Terán AK, Delgado Bolton RC. Response Assessment and Follow-Up by Imaging in Lung Tumours. Imaging and Interventional Radiology for Radiation Oncology 2020. [DOI: 10.1007/978-3-030-38261-2_23] [Reference Citation Analysis]
15 Brooks ED, Verma V, Senan S, De Baere T, Lu S, Brunelli A, Chang JY; International Association for the Study of Lung Cancer Advanced Radiation Technology Committee. Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC. J Thorac Oncol 2020;15:176-89. [PMID: 31712134 DOI: 10.1016/j.jtho.2019.10.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
16 Halpenny D, O'Dwyer E, Camacho Vasquez J, Shaverdian N, Girshman J, Ginsberg MS. Imaging of Novel Oncologic Treatments in Lung Cancer Part 2: Local Ablative Therapies. J Thorac Imaging 2020;35:37-48. [PMID: 31592831 DOI: 10.1097/RTI.0000000000000452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Mahon RN, Hugo GD, Weiss E. Repeatability of texture features derived from magnetic resonance and computed tomography imaging and use in predictive models for non-small cell lung cancer outcome. Phys Med Biol 2019. [PMID: 30978707 DOI: 10.1088/1361-6560/ab18d3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
18 Guckenberger M, Pöttgen C, Stuschke M. Radiation Therapy in Non-small-Cell Lung Cancer. Radiation Oncology 2019. [DOI: 10.1007/978-3-319-52619-5_34-1] [Reference Citation Analysis]
19 Guckenberger M, Aerts JG, Van Schil P, Weder W. The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion. J Thorac Cardiovasc Surg 2019;157:358-61. [PMID: 30557952 DOI: 10.1016/j.jtcvs.2018.09.107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Febbo JA, Gaddikeri RS, Shah PN. Stereotactic Body Radiation Therapy for Early-Stage Non–Small Cell Lung Cancer: A Primer for Radiologists. RadioGraphics 2018;38:1312-36. [DOI: 10.1148/rg.2018170155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
21 Nguyen TK, Senan S, Bradley JD, Franks K, Giuliani M, Guckenberger M, Landis M, Loo BW, Louie AV, Onishi H, Schmidt H, Timmerman R, Videtic GM, Palma DA. Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study. Practical Radiation Oncology 2018;8:e71-8. [DOI: 10.1016/j.prro.2017.10.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
22 Dyer BA, Daly ME. Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact? Semin Oncol 2017;44:303-9. [PMID: 29580432 DOI: 10.1053/j.seminoncol.2018.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ronden M, van Sörnsen de Koste J, Johnson C, Slotman B, Spoelstra F, Haasbeek C, Blom G, Bongers E, Warner A, Ward A, Palma D, Senan S. Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 2018;100:115-21. [DOI: 10.1016/j.ijrobp.2017.09.035] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
24 Weiss E, Newman B, Shah R. Differentiating Radiation Changes from Local Recurrence after SBRT for Lung Cancer: The Need for Better Decision Guidelines. IJRRT 2017;4. [DOI: 10.15406/ijrrt.2017.04.00106] [Reference Citation Analysis]
25 Postmus P, Kerr K, Oudkerk M, Senan S, Waller D, Vansteenkiste J, Escriu C, Peters S. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2017;28:iv1-iv21. [DOI: 10.1093/annonc/mdx222] [Cited by in Crossref: 795] [Cited by in F6Publishing: 917] [Article Influence: 159.0] [Reference Citation Analysis]
26 Larue RT, Defraene G, De Ruysscher D, Lambin P, van Elmpt W. Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures. Br J Radiol. 2017;90:20160665. [PMID: 27936886 DOI: 10.1259/bjr.20160665] [Cited by in Crossref: 209] [Cited by in F6Publishing: 221] [Article Influence: 34.8] [Reference Citation Analysis]
27 Nguyen TK, Palma DA. Pros: After stereotactic ablative radiotherapy for a peripheral early-stage non-small cell lung cancer, radiological suspicion of a local recurrence can be sufficient indication to proceed to salvage therapy. Transl Lung Cancer Res 2016;5:647-50. [PMID: 28151535 DOI: 10.21037/tlcr.2016.12.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol 2016;11:115. [PMID: 27600665 DOI: 10.1186/s13014-016-0693-8] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 14.8] [Reference Citation Analysis]
29 Mattonen SA, Ward AD, Palma DA. Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply? Br J Radiol 2016;89:20160113. [PMID: 27245137 DOI: 10.1259/bjr.20160113] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]